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Abstract
Background:  Asthma  and  rhinitis  have  a  complex  etiology,  depending  on  multiple  genetic  and
environmental  risk  factors.  An  increasing  number  of  susceptibility  genes  are  currently  being
identiﬁed, but  the  majority  of  reported  associations  have  not  been  consistently  replicated
across populations  of  different  genetic  backgrounds.
Purpose:  To  evaluate  whether  polymorphisms  of  IL4R  (rs1805015),  IL13  (rs20541),  IL17A
(rs2275913)  and  GSTP1  (rs1695)  genes  are  associated  with  rhinitis  and/or  asthma  in  adults
of Portuguese  ancestry.
Methods:  192  unrelated  healthy  individuals  and  232  patients,  83  with  rhinitis  and  149  with
asthma, were  studied.  All  polymorphisms  were  detected  by  real  time  polymerase  chain  reaction
(PCR) using  TaqMan  assays.
Results:  Comparing  to  controls,  signiﬁcant  association  with  asthma  was  observed  for  GSTP1
rs1695 AA  genotype  (odds  ratio  (OR)  --  1.96;  95%  CI  --  1.18  to  3.25;  p  =  0.010).  The  association
sustains for  allergic  asthma  (OR  --  2.17;  95%  CI  --  1.23  to  3.80;  p  =  0.007).  IL13  rs20541  GG
genotype  was  associated  with  less  susceptibility  to  asthma  (OR  --  0.55,  95%  CI  --  0.33  to  0.94,
p =  0.028).  Among  patients,  IL17A  rs2275913  AA  genotype  was  less  associated  with  asthma  than5%  CI  of  0.07  to  0.56;  p  =  0.002).  A  similar  association  was  found
pe  (OR  --  0.48;  95%  CI  of  0.25  to  0.93;  p  =  0.031).  There  were  no
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Conclusion:  These  results  support  the  existence  of  a  signiﬁcant  association  between  GSTP1
rs1695 and  IL13  rs20541  SNPs,  with  susceptibility  to  asthma,  in  the  population  studied.  Different
genotype proﬁles  of  IL17A  and  IL13  genes  seem  to  inﬂuence  the  clinical  pattern  of  disease
expression  mainly  conﬁned  to  the  upper  airways,  as  rhinitis,  or  including  the  lower  airways,  as
asthma.
© 2016  Sociedade  Portuguesa  de  Pneumologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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sthma  and  asthma-related  disorders,  such  as  sinusitis  and
hinitis,  are  complex  diseases  with  strong  genetic  and
nvironmental  components.1 Over  the  last  decades  their
revalence  has  been  increasing  worldwide,  with  a  signiﬁcant
conomic  impact  on  health  services.
Asthma  is  a  common  chronic  inﬂammatory  disease  of  the
ower  airways,  characterized  by  reversible  airﬂow  obstruc-
ion,  inﬂammation,  persistent  hyper-reactivity  and  airway
emodeling.2 Rhinitis  is  an  upper  airways  inﬂammatory
isease,  often  associated  with  asthma3 and  have  been  rec-
gnized  as  a  risk  factor  for  its  development  and  severity.4
Genetic  contribution  to  these  phenotypes  may  account
or  50--60%,5,6 so  dissecting  genetic  susceptible  proﬁles  may
rovide  insight  into  the  pathogenesis,  allowing  us  to  identify
ifferent  sub-phenotypes  and  also  contribute  to  ﬁnding  new
argeted  therapies.
An  increasing  number  of  asthma  susceptibility  loci  are
ontinuously  being  identiﬁed,  either  by  candidate  gene  stud-
es  or,  more  recently,  by  microarray-based  whole  genome
pproach,  the  genome-wide  association  (GWA)  studies.
esults  are  hampered  by  difﬁculties  common  to  other  com-
lex  diseases:  inconsistent  replication  of  results,  functional
ssociation  between  identiﬁed  loci  and  phenotype  is  not
bvious,  and  most  of  all,  allele  penetrance  is  low  and
henotype  variance  largely  remains  to  be  explained.7--10
ost  marker  SNPs  (single  nucleotide  polymorphisms)  are
ocalized  in  or  near-by  genes  encoding  proteins  directly
r  indirectly  involved  in  immunologic  response.  Recently,
WAs  have  revealed  that  different  allergic  diseases  with
ommon  immunological  physiopathology,  also  share  suscep-
ibility  loci.10
Interleukin-4  (IL4)  mediates  important  pro-inﬂammatory
unctions  in  allergic  phenotypes  and  has  principle  respon-
ibility  for  the  IgE  isotype  switch  by  B  lymphocytes.11 IL4
s  also  involved  in  T  helper  type  2  (TH2)  lymphocytes
ctivation,  induction  of  endothelium  modiﬁcations,  hyper-
ecretion  of  mucus  and  with  lung  remodeling  in  chronic
sthma.11 IL4  action  is  mediated  through  activation  of  its
eceptor  IL4R,  a  cell-surface  heterodimeric  complex.
Interleukin-13  (IL13)  is  one  of  the  cytokines  released
y  IL4  mediated  Th2  induced  cells  and  shares  most  of
L4  functions.  IL13  production  in  the  airway  promotes
he  survival  and  migration  of  eosinophils,  activation  of
acrophages,  increased  permeability  and  mucus  produc-Please  cite  this  article  in  press  as:  Resend
http://dx.doi.org/10.1016/j.rppnen.2016.06.009
ion  by  airway  epithelial  cells  and  stimulates  airways
yperresponsiveness.12 Huang  et  al.13 found  that  asthmatic
nd  rhinitis  patients  submitted  to  allergen-challenge  had  a
igniﬁcant  enhancement  of  IL13  gene  expression  at  mRNA
a
t
o
Und  protein  levels  in  bronchoalveolar  lavage  samples  com-
ared  with  the  saline-challenged  control  sites.
Interleukin-17A  (IL17A)  is  the  best  studied  member
f  IL17  family  of  cytokines.  It  is  mainly  produced  by
ctivated  T  cells.  Signaling  through  activation  NF-kappaB
nd  mitogen-activated  protein  kinases,  IL17A  regulates
ocal  tissue  inﬂammation  inducing  the  expression  of  pro-
nﬂammatory  cytokines,  neutrophil-recruiting  chemokines,
yclooxygenase-2  (COX2)  and  nitric  oxide  (NO).  IL17A  may
lso  modulate  the  activation  and  proliferation  of  B  cells,
hus  enhancing  IgE  production  and  has  been  associated  with
irway  hyperresponsiveness  and  remodeling.14,15
SNPs  from  IL4,  IL4R  and  IL13  genes  are  among  the  poly-
orphisms  most  frequently  implicated  in  susceptibility  to
sthma,  rhinitis  and  allergic  phenotypes  in  general,16 with
ome  of  these  SNPs  being  associated  with  increased  serum
gE  levels.17,18 Up  to  now  few  studies  are  available  on
he  association  with  genetic  polymorphisms  of  IL17A  family
embers.19--21
Reactive  oxygen  and  nitrogen  species,  originated  from  air
ollutants  or  released  by  inﬂammatory  cells  and  stressed
ronchial  epithelia,  are  major  contributors  to  asthma  and
sthma  related  phenotypes.22 Glutathione-S-transferases
GSTs)  are  enzymes  involved  in  the  cellular  detoxiﬁca-
ion  of  free  radicals.  A  missense  SNP  in  Glutathione
-transferase  P1  (GSTP1),  rs1695  (p.Ile105Val),  has  been
ssociated  with  differences  in  enzyme  activity  and  suscepti-
ility  to  environmental-induced  diseases,  including  asthma,
ut  results  remain  controversial.23,24
Frequencies  of  DNA  polymorphisms  vary  between  popu-
ations  of  diverse  ethnical  origins,  as  their  contributions  to
omplex  diseases,  therefore,  it  is  important  to  study  dif-
erent  populations.  In  this  study  we  evaluate  the  role  of
L4R  rs1805015,  IL13  rs20541,  IL17A  rs2275913  and  GSTP1
s1695  in  the  susceptibility  to  asthma  and  rhinitis  in  an  adult
opulation  of  Portuguese  ancestry.
aterials and methods
linical  samples
his  case--control  study  comprises  424  non  related  Cau-
asian  Portuguese  individuals,  including  232  patients  and
92  controls,  randomly  selected  from  a  larger  sample  thate  EP,  et  al.  Rev  Port  Pneumol.  2016.
nswered  a  home  inquiry  about  symptoms  of  asthma,  rhini-
is  and  sinusitis.  Individuals  willing  to  participate  were  than
bserved  at  the  Immunoallergology  Department  of  Coimbra
niversity  Hospitals.
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The  patient  population  was  subdivided  into  two  groups,
according  to  the  clinical  diagnosis,  using  ARIA  (Allergic  Rhini-
tis  and  Its  Impact  On  Asthma),4 GINA  (Global  Initiative  for
Asthma)2 and  EP3OS  (European  Position  Paper  on  Rhinosi-
nusitis  and  Nasal  Polyps  2007)25 criteria:  one  group  including
patients  with  rhinitis  but  no  asthma  and  another  group
including  patients  with  persistent  asthma,  which  could  also
have  rhinitis.  As  explained  in  ‘‘Results’’  section,  patients
with  both  rhinitis  and  asthma  were  grouped  with  those  who
only  had  asthma.  Controls  had  no  symptoms  related  to  respi-
ratory  system  and  no  history  of  any  allergic  disease.  Other
known  inﬂammatory  or  chronic  conditions,  including  can-
cer,  were  exclusion  criteria  for  both  patients  and  controls.
A  skin  prick  test  for  17  different  inhalant  allergens,  selected
according  to  the  recommendations  of  the  GA2LEN  (Global
Asthma  and  Allergy  European  Network),26 was  performed  on
all  patients  and  those  who  had  at  least  one  positive  result
were  considered  allergic.  The  test  was  considered  positive
when  wheal  diameter  was  ≥3  mm  and  controls  showed  sufﬁ-
cient  reaction.26 Participants  were  considered  allergic  only
in  the  presence  of  both  symptoms  and  a  positive  skin  prick
test.  The  local  ethics  committee  approved  the  study  and
patients  provided  informed  consent.
Genotyping
DNA  was  extracted  from  5  ml  of  frozen  peripheral  blood  by
standard  methods.  Characterization  of  the  four  SNPs  was
achieved  by  real  time  polymerase  chain  reaction  (PCR)  using
the  TaqMan  assays  (Applied  Biosystems),  iQTM  Supermix
(Bio-Rad  Laboratories)  and  10--30  ng  of  DNA,  in  a  7500  Fast
Real-Time  PCR  System  (Applied  Biosystems).  As  positive  con-
trols,  we  used  samples  previously  genotyped  by  automatic
sequencing  in  an  AbiPrism  3130  Genetic  Analyser  using  BD
v1.1  (Applied  Biosystems)  and  Sequencing  Analysis  Software
v5.2.  The  description  of  the  four  SNPs,  the  primers  used
in  sequencing  and  TaqMan  assay  references  are  depicted  in
Table  1.
Statistical  analysisPlease  cite  this  article  in  press  as:  Resend
http://dx.doi.org/10.1016/j.rppnen.2016.06.009
Statistical  analysis  was  developed  using  the  IBM® program
SPSS® (Statistical  Package  for  Social  Sciences)  version  20.
Fisher  exact-test,  2 was  applied  to  analyze  the  differ-
ence  between  the  three  groups.  Logistic  regression  models
q
(
e
Table  1  SNPs  evaluated.
Gene  SNP  Prim
IL4R  rs1805015;  TCC>CCC
missense  (p.Ser503Pro)
F  5′
R  5′
IL13 rs20541;  CAG>CGG
missense  (p.Gln144Arg)
F  5′
R  5′
IL17A rs2275913;  −197G>Ab
(regulatory  region)
F  5′
R  5′
GSTP1 rs1695;
ATC>GTC
missense  (p.Ile105Val)
F  5′
R  5′
a Primers used in genotyping by sequencing.
b NM 002190.2:c−197G>A. PRESS
3
ere  used  to  control  for  potential  confounders  and  to
valuate  the  associations  between  the  risk  of  disease  and
enetic  polymorphisms.  All  odds  ratios  (ORs)  with  95%  conﬁ-
ence  intervals  (CI)  were  adjusted  for  age,  sex  and  smoking
abits  and  p  <  0.05  was  considered  statistically  signiﬁcant.
hen  comparing  rhinitis  and  asthma  patients,  ORs  were  also
djusted  for  atopy.
esults
 preliminary  analysis  revealed  that  for  distribution  of
NP  variants,  smoking  habits  and  atopy  (positive  skin  prick
est  results),  there  were  no  statistically  signiﬁcant  differ-
nces  between  patients  associating  asthma  and  rhinitis  and
atients  only  with  asthma  (Supplementary  Table  1).  For  this
eason,  and  because  asthma  is  considered  a more  aggressive
henotype,  the  two  groups  were  joined  together,  so  patients
ere  further  on  classiﬁed  as  having  rhinitis  or  asthma,  as
escribed  in  Table  2.  The  cohort  of  83  patients  with  rhini-
is  had  a  mean  age  of  48.50  years  (SD  =  15.17)  and  63.9%
emales.  The  group  of  149  asthmatic  patients  was  younger,
ith  a  mean  age  of  39.32  years  (SD  =  14.04)  and  66.4%
ere  females.  The  control  group  had  a  mean  age  of  56.06
ears  (SD  =  19.48)  and  52.1%  females.  According  to  results  of
kin  prick  test,  allergy  was  more  frequent  among  asthmatic
atients  (78.5%;  Table  2).
The  Hardy--Weinberg  equilibrium  was  veriﬁed  for  the  four
olymorphisms  (p  >  0.05).  The  frequency  of  GSTP1  rs1695  AA
enotype  was  signiﬁcantly  higher  in  patients  with  asthma
han  in  controls  (49.0%  vs.  33.9%;  OR  --  1.96,  95%  CI  --  1.18
o  3.25;  p  =  0.010)  (Table  3).  When  only  considering  patients
ith  allergic  asthma  (data  not  shown)  results  were  similar
OR  --  2.17,  95%  CI  --  1.23  to  3.80;  p  =  0.007).  IL13  rs20541
G  genotype  was  signiﬁcantly  less  prevalent  in  asthma  cases
62.6%)  than  in  controls  (70.8%)  (OR  --  0.55,  95%  CI  --  0.33  to
.94;  p  =  0.028)  (Table  3).
Among  patients,  IL13  rs20541  GG  genotype  was  less
requently  associated  with  asthma  than  with  rhinitis  (OR
-  0.48,  95%  CI  --  0.25  to  0.93;  p  =  0.031)(Table  4).  The
L17A  rs2275913  AA  genotype  was  also  signiﬁcantly  less  fre-e  EP,  et  al.  Rev  Port  Pneumol.  2016.
uent  in  asthmatic  patients  (5.4%)  than  in  rhinitis  patients
16.9%)(OR  --  0.20,  95%  CI  --  0.07  to  0.56;  p  =  0.002)  (Table  4).
For  IL4R  rs1805015,  there  were  no  signiﬁcant  differ-
nces  in  the  distribution  of  allelic  and  genotypic  frequencies
er  sequencea TaqMan  assay  ID
ATGCCTTCTTCCACCTTC
CATCTCGGGTTCTACTTCC
C  8903092  20
CCGTGAGGACTGAATGAG
CACAGGCTGAGGTCTAAG
C  2259921  20
ATGACACCAGAAGACCTAC
TGTGCCTGCTATGAGATG
C  15879983  10
TGTGGCAGTCTCTCATCC
GCAGGTTGTGTCTTGTCC
C  3237198  20
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Table  2  Characteristics  of  patients  and  controls.
Rhinitis
n  =  83  (%)
Asthma
n  =  149  (%)
Controls
n  =  192  (%)
p-Value
Gender
Male  30  (36.1) 50  (33.6) 92  (47.9) 0.005
Female  53  (63.9)  99  (66.4)  100  (52.1)
Age (years)
Mean  (SD)  48.50  (15.17)  39.32  (14.04)  56.06  (19.48)  <0.001
Smoking habits
No  smoking  54  (65.9)  104  (71.2)  121  (64.4) NS
Smoking  28  (34.1)  42  (28.8)  67  (35.6)
Skin test  positivea 40  (48.2)  117  (78.5)  NA  <0.001
a Test with at least one positive result.
NA -- not available.
b
d
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dSD -- standard deviation.
NS -- without statistical signiﬁcance.
etween  patients  and  controls  (Table  3)  or  between  the  two
isease  phenotypes  (data  not  shown).
iscussion
n  this  work  we  evaluate  the  role  of  polymorphisms  of  four
enes,  IL4R, IL13, IL17A, and  GSTP1  in  the  susceptibility  to
wo  related  phenotypes,  asthma  and  rhinitis.
As  expected,27 patients  were  mostly  of  female  gender.  InPlease  cite  this  article  in  press  as:  Resend
http://dx.doi.org/10.1016/j.rppnen.2016.06.009
greement  with  previous  studies,28 our  results  suggest  that
ost  patients  with  asthma  have  allergen  sensitization.
Comparing  patients  and  controls,  GSTP1  rs1695  AA  geno-
ype  conferred  about  twofold  risk  for  developing  asthma  and
o
T
G
a
Table  3  Comparative  study  of  genotypic  frequencies  in  controls  
Controls
n  (%)
Rhinitis
n  (%)
p-Valu
GSTP1  rs1695
Ile/Ile  (AA)  65  (33.9)  35  (42.2)  0.260  
Ile/Val (AG)  97  (50.5)  40  (48.2)  0.849  
Val/Val (GG)  30  (15.6)  8  (9.6)  0.202  
IL13 rs20541
Arg/Arg  (GG)  136  (70.8)  60  (73.2)  0.686  
Gln/Arg (AG)  52  (27.1)  20  (24.4)  0.694  
Gln/Gln (AA)  4  (2.1)  2  (2.4)  0.948  
IL17 rs2275913
GG  94  (49.0) 28  (33.7)  0.068  
AG 81  (42.2)  41  (49.4)  0.532  
AA 17  (8.9)  14  (16.9)  0.072  
IL4R rs1805015
Ser/Ser  (TT)  140  (73.3)  65  (78.3)  0.374  
Ser/Pro (TC)  43  (22.5)  15  (18.1)  0.447  
Pro/Pro (CC)  8  (4.2)  3  (3.6)  0.707  
a Controls vs rhinitis
b Controls vs asthma
c AdjOR -- Adjusted Odds Ratio for age, gender and smoking habits.llergic  asthma.  These  results  of  a  Portuguese  population  are
n  accordance  with  previous  studies  that  have  associated  the
 variant  with  a  higher  risk,29 or  the  G  (Val)  variant  with  a
ower  risk30,31 to  develop  asthma  and  allergic  phenotypes.
et  a  meta-analysis23 only  suggested  a  possible,  weak  pro-
ective  effect  of  the  G  (Val)  allele.  Like  other  authors,  we
ound  no  evidence  of  a  correlation  between  GSTP1  SNP  and
hinitis.32
GSTs  play  important  roles  in  airway  antioxidant
efenses33 and  GSTP1  enzyme  contributes  to  more  than  90%e  EP,  et  al.  Rev  Port  Pneumol.  2016.
f  GST-derived  enzyme  activity  in  human  lung  epithelium.34
he  rs1695  SNP  has  been  associated  with  differences  in
STP1  substrate  afﬁnities.35 A  recent  study36 showed  that
sthma  patients  who  have  homozygosity  for  A  (Ile)  allele
and  patients.
ea Asthma
n  (%)
p-Valueb AdjORc,b
(95%  CI)
73  (49.0)  0.010  1.96  (1.18--3.25)
61  (40.9)  0.418
15  (10.1)  0.418
92  (62.6)  0.028  0.55  (0.33--0.94)
50  (34.0)  0.908
5  (3.4)  0.908
69  (46.6)  0.552
71  (48.0)  0.978
8  (5.4)  0.230
115  (77.2)  0.939
30  (20.1)  0.614
4  (2.7)  0.199
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Table  4  Comparative  study  of  IL17A  and  IL13  polymorphisms  genotypic  frequencies  between  the  two  patient  groups.
Rhinitis
n  (%)
Asthma
n  (%)
p-Value  AdjOR
(95%  CI)a
IL13  rs20541
Arg/Arg  (GG) 60  (73.2) 92  (62.6) 0.031 0.48  (0.25--0.93)
Gln/Arg (AG) 20  (24.4) 50  (34.0) 0.797
Gln/Gln  (AA)  2  (2.4)  5  (3.4)  0.797
IL17 rs2275913
GG  28  (33.7)  69  (46.6)  0.97
AG 41  (49.4)  71  (48.0)  0.97
AA 14  (16.9)  8  (5.4)  0.002  0.20  (0.07--0.56)
a AdjOR -- Adjusted Odds Ratio for age, gender, atopy and smoking habits.
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CFor the IL4R and GSTP1 polymorphism’ analyzed, there were no
between patients.
are  more  likely  to  be  affected  by  air  pollutants.  These  ﬁnd-
ings  substantiate  the  functional  relevance  of  the  SNP,37 and
support  our  results.  Yet,  we  are  aware  that  this  genetic
effect  can  be  affected  by  environment-induced  epigenetic
modiﬁcations  that  inﬂuence  gene  expression  and  ultimately,
the  level  of  enzymatic  activity.38,39 Epigenetic  regulation  is
tissue-speciﬁc  and  may  account  for  some  of  the  differences
in  GSTP1  role  between  upper  and  lower  airways.
For  IL13  SNP,  our  results  suggest  that  homozygosity  for  G
allele,  corresponding  to  arginine  (Arg)  variant,  may  decrease
susceptibility  to  asthma.  IL13  polymorphisms  have  repeat-
edly  being  associated  with  increased  IgE  serum  levels,
allergy  and  asthma.16,40 The  association  of  rs20541  with
allergic  rhinitis  was  reported  in  a  recent  meta-analysis  of
an  Asian  population.41
IL13  rs20541  (CAG>CGG)  results  in  the  non-conservative
replacement  of  a  neutral  glutamine  (Gln)  for  a  positively
charged  arginine  (Arg)  in  the  IL13    helix  of  D  domain,
the  region  that  is  thought  to  interact  with  IL4R/IL13R1
heterodimers.42 The  A  allele  has  been  associated  with
increased  IL13  expression43 and  a  lower  afﬁnity  for  the
IL13  receptor  2  chain  (IL13R2),  which  is  a  decoy  recep-
tor  that  antagonizes  inﬂammation  and  tissue  remodeling.44
These  observations  point  to  a  lower  inﬂammatory  activ-
ity  of  arginine  variant  (G  allele)  comparing  with  glutamine
(A  allele),  supporting  the  association  with  a  decreased  sus-
ceptibility  to  asthma.
In  contrast  to  other  studiess,17,41 we  could  not  conﬁrm
the  same  correlations  for  rhinitis.  The  difference  in  results
may  be  explained  by  the  fact  that  upper  airways  patency
is  largely  inﬂuenced  by  vascular  tone,  whereas  in  the  lower
airways,  smooth  muscle  function  is  determinant.45 IL13  was
shown  to  directly  interfere  with  airway  smooth  muscle  cell
responsiveness  by  enhancing  agonist-induced  contractility
and  calcium  signals,  a  mechanism  that  may  be  mediated
by  stromal  interaction  molecule-1  (STIM1),  a  sarcoplasmic
reticulum  protein  involved  in  the  regulation  of  intracellular
Ca2+ concentrations.46
Comparing  both  groups  of  patients,  IL17A  rs2275913  AA
genotype  was  less  frequently  associated  with  asthma  thanPlease  cite  this  article  in  press  as:  Resend
http://dx.doi.org/10.1016/j.rppnen.2016.06.009
with  rhinitis,  reinforcing  the  difference  between  the  genetic
proﬁles  of  these  phenotypes.  This  SNP  is  located  in  5′ regula-
tory  region,  within  a  binding  motif  for  the  nuclear  factor  of
activated  T  cells  (NFAT),  which  is  a  critical  regulator  of  the
W
b
riﬁcant differences in the distribution of genotypic frequencies
L17A  promoter.  Peripheral  blood  level  determination  and
ene  reporter  assays  showed  that  the  A  variant  was  associ-
ted  with  increased  levels  of  IL17A  expression  and  displayed
 higher  afﬁnity  for  NFAT.47
For  rhinitis,  our  data  concur  with  the  functional  rele-
ance  of  A  variant.  IL17A  is  known  to  be  a  proinﬂammatory,
eukocyte-derived  cytokine  that  targets  epithelial  cells48
nd  that  seems  to  play  a  central  role  in  rhinitis.14 IL17A
xpression  in  the  nasal  mucosa  was  associated  with  the
athophysiology  of  allergic  rhinitis,  including  disease  sever-
ty  and  local  eosinophilia.49
In  asthma,  increased  expression  of  IL17A  has  been
escribed  mainly  in  severe  and  non-allergic  forms.50,51 The
ajority  of  patients  included  in  our  study  had  moderate
sthma,  which  may  account  for  the  negative  association
bserved  with  the  higher  inﬂammatory  activity  A  allele.
einforcing  our  results,  Lei  et  al.52 describe  similar  serum
evels  of  IL-17A  between  asthmatic  and  normal  controls.
lobally,  controversial  results  have  been  published,  with
tudies  suggesting  that  different  polymorphisms  of  IL17A  and
L17F  may  contribute  both  to  susceptibility  or  resistance  to
sthma  or  allergic  rhinitis.19--21
No  signiﬁcant  association  was  observed  between  IL4R
s1805015  polymorphism  with  rhinitis  or  asthma.  Although
his  association  was  conﬁrmed  in  recent  GWA  studies,9
ontradictory  reports  exist  and  results  frequently  differ
etween  populations.16,18
The  difference  in  results  between  our  data  and  some  pre-
ious  reports  is  a  common  issue  in  complex  disease  research.
ifferences  in  population  genetic  backgrounds,  in  sample
ize  and  selection,  phenotype  classiﬁcation,  in  environmen-
al  exposure  and  epigenetic  mechanisms,  contribute  to  the
esults  divergence.
To  overcome  limitations  of  this  study,  in  future  work
t  will  be  important  to  enlarge  the  population  samples  to
e  analyzed  and  to  deﬁne  more  speciﬁc  and  homogeneous
henotypes.
onclusionse  EP,  et  al.  Rev  Port  Pneumol.  2016.
e  describe  the  existence  of  a  signiﬁcant  association
etween  GSTP1  rs1695  and  IL13  rs20541  polymorphisms,
espectively  with  higher  and  reduced  susceptibility  to
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sthma.  For  patients  that  develop  reactive  inﬂammatory
espiratory  diseases,  IL17A  rs2275913  and  IL13  rs20541
olymorphisms  inﬂuence  the  predominant  upper  airways
rhinitis)  or  lower  airways  (asthma)  clinical  pattern.  These
esults  also  support  the  hypothesis  that  the  genetic  suscep-
ibility  proﬁles  of  asthma  and  isolate  chronic  rhinitis  are  not
quivalent.
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